Searched for
LUPIN PLANTS
These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...- Beyond rice, wheat: Why India must revive native ‘orphan crops’ for protein securityIndia can boost nutrition security, cut import dependence, and build a global smart protein industry by scaling climate-resilient indigenou...
- Bernstein initiates coverage on 6 pharma stocks, cites 3 major tailwinds for healthcare sectorBernstein has initiated coverage on six Indian pharma stocks, with Zydus Lifesciences as its top choice. The brokerage sees strong future g...
- Small & midcaps rally! Wockhardt, Coforge, other stocks surge up to 14%. Do you own any?Smallcap and midcap stocks surged on Wednesday, outperforming broader market indices with gains of around 1% each. This rally was fueled by...
- Pharma Q4 outlook mixed: Hospitals steady, generics face revlimid dragIndian pharma and healthcare firms face a mixed March quarter. While hospitals anticipate steady growth, generic drugmakers grapple with lo...
- Bain Capital sole contender for Vitabiotics buyBain Capital has emerged as the frontrunner to acquire Vitabiotics, as rival bidders TPG Capital and EQT exit the process, potentially lowe...
- SC upholds Maharashtra government's power to withdraw duty breaks for captive unitsThe Supreme Court has ruled in favor of the Maharashtra government. Companies will now have to pay electricity duty on power generated by t...
- Sunsure Energy to supply 21 MW solar power to Lupin's Tarapur facilitySunsure Energy has signed an agreement to supply 21MW solar power to Lupin's Tarapur facility from its 100 MW solar plant in Solapur. This ...
- USFDA classifies inspection of Lupin's Tarapur facility as 'Official Action Indicated'According to FDA's definitions, Official Action Indicated means "objectionable conditions were found and regulatory administrative sanction...
- Sell Lupin, target Rs 800: Elara CapitalSell Lupin at a price target of Rs 800.
- Pharma cos staring at some margin pressure: Surajit Pal, Prabhudas Lilladher"Non-sterile plants getting stuck for such a long time are really surprising."
- Lupin slumps to 4-year low as USFDA issues warning letter for Goa, Indore plantsThe warning letter was issued on Monday for Pithampur unit II of Indore and its Goa plant.
- USFDA finds minor violations at Lupin's Dabhasa plantDrug firm Lupin today said US health regulator has voiced minor concerns after completing the inspection of its Dabhasa facility in Gujarat.
- Lupin gets 3 observations from USFDA for Mandideep plantHowever, the company said the observations were "minor in nature" and would not lead to any disruption of product supply from the location.
- Lupin receives nine observations from USFDA for Goa plant"We wish to state that the USFDA inspected company's Goa facility last week and cited nine observations," Lupin said in a regulatory filing.
- Lupin's subsidiary Kyowa to set up plant in JapanKyowa Pharmaceutical Industry Co is a wholly-owned subsidiary of the the Mumbai-based firm. It has a manufacturing facility at Sanda, Japan.
- Toxic nectar affects behaviour of insect pollinatorsNatural toxins in nectar and pollen can poison insects and affect their memory, behaviour and reproductive success, researchers have found.
- Lupin plants get USFDA nod; co to sell new productsDrug maker Lupin has received clearance from the US drug regulator for its plant at Mandideep in Madhya Pradesh, allowing the Mumbai-based ...
- Lupin’s MP plant under USFDA scannerThe US Food and Drug Administration (USFDA) has found 15 manufacturing deficiencies at one of Lupin’s plant in Madhya Pradesh (MP) during t...
- Lupin proposes to set up a SEZ in MaharashtraPharma major Lupin proposes to set up a sector-specific Special Economic Zone (SEZ) in Maharashtra to produce API and formulations with an ...
Load More
